Michael Gelband ExodusPoint Capital Management
Michael Gelband is a co-founder of ExodusPoint Capital Management, a multi-strategy hedge fund launched by veterans of larger alternative platforms. The firm pursues diversified strategies across asset classes with a focus on risk-managed absolute returns. Gelband’s firm is followed as part of the newer generation of multi-strategy complexes.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Global Payments
GPN
|
+$308M |
| 2 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$76.7M |
| 3 |
American Homes 4 Rent
AMH
|
+$69.4M |
| 4 |
Equinix
EQIX
|
+$51.2M |
| 5 |
Americold
COLD
|
+$48.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NiSource
NI
|
+$77.7M |
| 2 |
Linde
LIN
|
+$71M |
| 3 |
DTE Energy
DTE
|
+$57.1M |
| 4 |
Freeport-McMoran
FCX
|
+$51.7M |
| 5 |
FedEx
FDX
|
+$44.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 11.05% |
| 2 | Technology | 9.71% |
| 3 | Healthcare | 9.12% |
| 4 | Real Estate | 6.85% |
| 5 | Utilities | 6.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1476
Brookdale Senior Living
BKD
$2.91B
| $354K | ﹤0.01% |
83,819
+72,695
| +653% | +$281K |
|
|
FORG
1477
DELISTED
ForgeRock, Inc.
FORG
| $353K | ﹤0.01% |
+17,183
| New | +$344K |
|
1478
NCR Voyix
VYX
$1.12B
| $352K | ﹤0.01% |
+22,750
| New | +$328K |
|
1479
Boston Omaha
BOC
$424M
| $351K | ﹤0.01% |
18,631
+1,108
| +6% | +$22.5K |
|
1480
CleanSpark
CLSK
$3.27B
| $350K | ﹤0.01% |
+81,543
| New | +$328K |
|
1481
HealthStream
HSTM
$844M
| $349K | ﹤0.01% |
14,212
+778
| +6% | +$19.3K |
|
1482
Methode Electronics
MEI
$570M
| $349K | ﹤0.01% |
10,398
-5,849
| -36% | -$239K |
|
1483
RingCentral
RNG
$5.48B
| $347K | ﹤0.01% |
10,591
-206,376
| -95% | -$6.34M |
|
|
WSR
1484
DELISTED
Whitestone REIT
WSR
| $343K | ﹤0.01% |
35,387
+3,959
| +13% | +$35.7K |
|
|
EA
1485
DELISTED
Electronic Arts
EA
| $341K | ﹤0.01% |
+2,630
| New | +$333K |
|
1486
El Pollo Loco
LOCO
$478M
| $341K | ﹤0.01% |
+38,884
| New | +$364K |
|
|
ACH
1487
Accendra Health
ACH
$89.2M
| $341K | ﹤0.01% |
+17,891
| New | +$319K |
|
1488
REX American Resources
REX
$1.37B
| $341K | ﹤0.01% |
+19,612
| New | +$304K |
|
1489
inTEST
INTT
$146M
| $340K | ﹤0.01% |
+12,966
| New | +$286K |
|
1490
Onto Innovation
ONTO
$17.8B
| $339K | ﹤0.01% |
2,909
-786
| -21% | -$75K |
|
1491
Bionano Genomics
BNGO
$14.7M
| $337K | ﹤0.01% |
+920
| New | +$415K |
|
1492
Helix Energy Solutions
HLX
$1.47B
| $337K | ﹤0.01% |
+45,672
| New | +$325K |
|
1493
Invesco Mortgage Capital
IVR
$801M
| $337K | ﹤0.01% |
29,410
+5,139
| +21% | +$55K |
|
1494
Roivant Sciences
ROIV
$26.3B
| $336K | ﹤0.01% |
33,380
-454,708
| -93% | -$4.07M |
|
|
LGF.B
1495
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
| $335K | ﹤0.01% |
+40,095
| New | +$395K |
|
1496
Banc of California
BANC
$2.95B
| $334K | ﹤0.01% |
+28,862
| New | +$333K |
|
|
SFIX
1497
Stitch Fix
SFIX
$423M
| $334K | ﹤0.01% |
+86,759
| New | +$329K |
|
|
AMED
1498
DELISTED
Amedisys
AMED
| $332K | ﹤0.01% |
3,634
-43,620
| -92% | -$3.58M |
|
1499
MBIA
MBI
$250M
| $331K | ﹤0.01% |
38,330
+23,867
| +165% | +$215K |
|
|
SVC
1500
Service Properties Trust
SVC
$1.03B
| $331K | ﹤0.01% |
7,612
-8,963
| -54% | -$394K |
|
Similar funds
Michael Gelband's Q2 2023 Portfolio in Review
As of Q2 2023, Michael Gelband held 2,377 positions worth $12.3B, up 1.9% from $12.1B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Michael Gelband's Q2 2023 filing shows 669 new, 496 increased, 623 reduced and 582 closed positions. Its largest new stake was Pioneer Natural Resource Co.: 364,360 shares worth $75.5M. The largest sale was NiSource, an estimated $77.7M.
By sector, the portfolio is most concentrated in Industrials at 11% of assets, up from 11% a quarter earlier, followed by Technology and Healthcare.
- Michael Gelband's largest Q2 2023 buy was Pioneer Natural Resource Co.: 364,360 shares worth $75.5M.
- Michael Gelband added most to Global Payments in Q2 2023, an estimated $308M increase.
- Michael Gelband's biggest Q2 2023 reduction was NiSource, cutting an estimated $77.7M.
- Michael Gelband fully exited L3Harris in Q2 2023, selling an estimated $44.7M.
- Michael Gelband's ten largest holdings make up 25% of its $12.3B portfolio in Q2 2023.
- Michael Gelband opened 669 new positions and closed 582 in Q2 2023.
- Michael Gelband's portfolio value rose 1.9% quarter-over-quarter to $12.3B.
Based on ExodusPoint Capital Management's 13F filing for Q2 2023, filed 11 Aug 2023.